Ropharma Bras (RPH) - Total Liabilities
Based on the latest financial reports, Ropharma Bras (RPH) has total liabilities worth RON688.42 Million RON (≈ $158.07 Million USD) as of December 2024. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Also explore net asset momentum of Ropharma Bras to track the company's year-over-year net asset growth rate.
Ropharma Bras - Total Liabilities Trend (2021–2025)
This chart illustrates how Ropharma Bras's total liabilities have evolved over time, based on quarterly financial data. See RPH FCF generation index to measure how efficiently the company converts operating cash flow to free cash.
Ropharma Bras Competitors by Total Liabilities
The table below lists competitors of Ropharma Bras ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
ChemX Materials Ltd
AU:CMX
|
Australia | AU$302.97K |
|
Jiyuan Packaging Holdings Ltd
TW:8488
|
Taiwan | NT$3.01 Billion |
|
Excel Force MSC Bhd
KLSE:0065
|
Malaysia | RM17.70 Million |
|
Altech Chemicals Ltd
F:A3Y
|
Germany | €16.45 Million |
|
NamSys Inc
V:CTZ
|
Canada | CA$1.55 Million |
|
Shradha Infraprojects Limited
NSE:SHRADHA
|
India | Rs2.41 Billion |
|
Tali Resources Ltd
AU:TR2
|
Australia | AU$166.99K |
|
Flagship Investments Ltd
AU:FSI
|
Australia | AU$21.28 Million |
Liability Composition Analysis (2021–2025)
This chart breaks down Ropharma Bras's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see Ropharma Bras (RPH) market capitalisation.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 1.05 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 2.81 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.73 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Ropharma Bras's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Ropharma Bras (2021–2025)
The table below shows the annual total liabilities of Ropharma Bras from 2021 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-06-30 | RON688.42 Million ≈ $158.07 Million |
+23.83% |
| 2024-06-30 | RON555.92 Million ≈ $127.65 Million |
+3.57% |
| 2023-06-30 | RON536.76 Million ≈ $123.25 Million |
+121.43% |
| 2022-06-30 | RON242.40 Million ≈ $55.66 Million |
-5.17% |
| 2021-06-30 | RON255.62 Million ≈ $58.69 Million |
-- |
About Ropharma Bras
S.C. Ropharma S.A. operates a chain of pharmacies in Romania. The company distributes over-the-counter medications, food supplements, cosmetics, perfumes, medical devices, dermato-cosmetics, para pharmaceuticals, and other medicines through pharmaceutical warehouses. It also offers cardiovascular, dermatological, digestive, ophthalmological, osteoarticular, respiratory, urogenital, and diabetes m… Read more